Investigation of the efficacy of adjunctive therapy with bioavailability-boosted curcuminoids in major depressive disorder
- PMID: 25091591
- DOI: 10.1002/ptr.5211
Investigation of the efficacy of adjunctive therapy with bioavailability-boosted curcuminoids in major depressive disorder
Abstract
Current medications have limited efficacy in controlling the symptoms of major depressive disorder (MDD), and are associated with several adverse events on long-term use. Curcuminoids are extremely safe and multifunctional phytopharmaceuticals that have been shown to alleviate depressive symptoms in a variety of experimental models. The present study aimed to investigate the efficacy of curcuminoids as an add-on to standard antidepressants in patients with MDD. One hundred and eleven subjects were assigned to standard antidepressive therapy plus curcuminoids-piperine combination (1000-10 mg/day; n=61) or standard antidepressive therapy alone (n=50) for a period of 6 weeks. Efficacy measures were changes in the psychological status on the basis of the Hospital Anxiety and Depression Scale (HADS) and Beck Depression Inventory II (BDI-II). The BDI-II and HADS total and subscale scores were reduced by the end of trial in both study groups. There were significantly greater reductions in total HADS score and subscales of anxiety and depression in the curcuminoids versus control group (p<0.001). Likewise, reductions in BDI-II total score and scores of somatic and cognitive subscales were found to be greater in the curcuminoids compared with control group (p<0.001). Co-administration of curcuminoids with piperine may be used as a safe and effective add-on to standard antidepressants in patients with MDD.
Keywords: anxiety; clinical trial; curcumin; depression; piperine.
Copyright © 2014 John Wiley & Sons, Ltd.
Similar articles
-
Effects of Curcuminoids Plus Piperine on Glycemic, Hepatic and Inflammatory Biomarkers in Patients with Type 2 Diabetes Mellitus: A Randomized Double-Blind Placebo-Controlled Trial.Drug Res (Stuttg). 2018 Jul;68(7):403-409. doi: 10.1055/s-0044-101752. Epub 2018 Feb 19. Drug Res (Stuttg). 2018. PMID: 29458218 Clinical Trial.
-
Novel Augmentation Strategies in Major Depression.Dan Med J. 2017 Apr;64(4):B5338. Dan Med J. 2017. PMID: 28385173 Review.
-
Piperine and Its Role in Chronic Diseases.Adv Exp Med Biol. 2016;928:173-184. doi: 10.1007/978-3-319-41334-1_8. Adv Exp Med Biol. 2016. PMID: 27671817 Review.
-
Lipid-modifying effects of adjunctive therapy with curcuminoids-piperine combination in patients with metabolic syndrome: results of a randomized controlled trial.Complement Ther Med. 2014 Oct;22(5):851-7. doi: 10.1016/j.ctim.2014.07.006. Epub 2014 Jul 22. Complement Ther Med. 2014. PMID: 25440375 Clinical Trial.
-
Effects of Curcuminoids-Piperine Combination on Systemic Oxidative Stress, Clinical Symptoms and Quality of Life in Subjects with Chronic Pulmonary Complications Due to Sulfur Mustard: A Randomized Controlled Trial.J Diet Suppl. 2016;13(1):93-105. doi: 10.3109/19390211.2014.952865. Epub 2014 Aug 29. J Diet Suppl. 2016. PMID: 25171552 Clinical Trial.
Cited by
-
Curcumin as a Multifunctional Spice Ingredient against Mental Disorders in Humans: Current Clinical Studies and Bioavailability Concerns.Life (Basel). 2024 Apr 5;14(4):479. doi: 10.3390/life14040479. Life (Basel). 2024. PMID: 38672750 Free PMC article. Review.
-
The progression of inorganic nanoparticles and natural products for inflammatory bowel disease.J Nanobiotechnology. 2024 Jan 3;22(1):17. doi: 10.1186/s12951-023-02246-x. J Nanobiotechnology. 2024. PMID: 38172992 Free PMC article. Review.
-
A Spectrum of Solutions: Unveiling Non-Pharmacological Approaches to Manage Autism Spectrum Disorder.Medicina (Kaunas). 2023 Aug 31;59(9):1584. doi: 10.3390/medicina59091584. Medicina (Kaunas). 2023. PMID: 37763703 Free PMC article. Review.
-
Cool the Inflamed Brain: A Novel Anti-inflammatory Strategy for the Treatment of Major Depressive Disorder.Curr Neuropharmacol. 2024;22(5):810-842. doi: 10.2174/1570159X21666230809112028. Curr Neuropharmacol. 2024. PMID: 37559243 Free PMC article. Review.
-
Neuroprotective Effects of Black Pepper and Its Bioactive Compounds in Age-Related Neurological Disorders.Aging Dis. 2023 Jun 1;14(3):750-777. doi: 10.14336/AD.2022.1022. Aging Dis. 2023. PMID: 37191428 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical